2022
DOI: 10.1021/acsami.2c11089
|View full text |Cite
|
Sign up to set email alerts
|

Aptamer-Gold Nanocage Composite for Photoactivated Immunotherapy

Abstract: Immune checkpoint blockade (ICB) has been hailed as the hope for conquering cancer as ICB could produce a significant and durable response to tumor cells. However, the high cost and severe side effects of ICB drugs limited their application for further anticancer therapy. Here, we developed a photoactivated immunotherapy nanoplatform (Apt@AuNC). This nanoplatform could target tumor tissues via enhanced penetration retention (EPR) effect and the aptamer (Apt) could be released from Apt@AuNC in tumor sites via i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 26 publications
0
14
0
Order By: Relevance
“…As aptamer technology and coupling technology continue to develop, aptamers can be coupled with a variety of functional carriers to form numerous composite materials with an increasingly diverse range of structures and functions. Multifunctional integrated design strategies effectively merge the advantages and characteristics of functional carriers and aptamers while circumventing their disadvantages, providing a potential means to regulate aptamer–protein interactions. In this part, we give a detailed discussion about how functional modifications of aptamers affect aptamer–protein interactions.…”
Section: Regulation Methods Of Aptamer–protein Interactionsmentioning
confidence: 99%
“…As aptamer technology and coupling technology continue to develop, aptamers can be coupled with a variety of functional carriers to form numerous composite materials with an increasingly diverse range of structures and functions. Multifunctional integrated design strategies effectively merge the advantages and characteristics of functional carriers and aptamers while circumventing their disadvantages, providing a potential means to regulate aptamer–protein interactions. In this part, we give a detailed discussion about how functional modifications of aptamers affect aptamer–protein interactions.…”
Section: Regulation Methods Of Aptamer–protein Interactionsmentioning
confidence: 99%
“…When the nanovesicles were used with laser irradiation, tumor growth was safely completely inhibited in a 4T1 subcutaneous mice model. Song et al proposed coating silver nanocubes with gold followed by addition of oligomers . Reaction with a complementary sequence, extended with a labeled PD-L1 aptamer, yielded a functional nanocube of 100 nm size.…”
Section: Aptamers For Co-targetingmentioning
confidence: 99%
“…Song et al proposed coating silver nanocubes with gold followed by addition of oligomers. 55 Reaction with a complementary sequence, extended with a labeled PD-L1 aptamer, yielded a functional nanocube of 100 nm size. After selective accumulation in tumor sites thanks to the EPR effect, laser-induced photothermal activation released the aptamers in the tumor environment, leading to a reduced tumor growth in B16F10 tumor mice models and increased levels of IFN-γ, TNF-α, IL-12P40, and IL-6.…”
Section: ■ Aptamers For Co-targetingmentioning
confidence: 99%
“…All along, malignant tumors affect human health and quality of life. , With the efforts of researchers, nanomaterial delivery systems have achieved outstanding therapeutic efficacy through improved targeting, controlled drug release, and reduced systemic toxicity. However, several biological and physical barriers limit the delivery of protein biologics encapsulated nanoparticles to tumor tissues . Due to their specificity, protein biologics are excellent candidates for many tumor therapeutic targets. Currently, the technical challenges and activity maintenance of protein biologics in the delivery process greatly limit their application in the field of tumor therapy .…”
Section: Introductionmentioning
confidence: 99%
“…All along, malignant tumors affect human health and quality of life. 1,2 With the efforts of researchers, nanomaterial delivery systems have achieved outstanding therapeutic efficacy through improved targeting, controlled drug release, and reduced systemic toxicity. 3−5 However, several biological and physical barriers limit the delivery of protein biologics encapsulated nanoparticles to tumor tissues.…”
Section: Introductionmentioning
confidence: 99%